Reflect Scientfc Stock Price, News & Analysis

Reflect Scientific, Inc. (Symbol: RSCF) has announced the effectiveness of its amended Registration Statement on Form 10, now categorizing the company as a 'fully-reporting issuer' with the SEC. This status allows Reflect Scientific to resume regular filings of Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, enhancing corporate transparency. CEO Kim Boyce emphasized that these filings will be accessible on both the SEC's website and Reflect Scientific's site. The company specializes in cryogenic cooling technologies for various industries, including biotechnology and pharmaceuticals.

Reflect Scientific, Inc. (RSCF) announced its Q1 2021 financial results, highlighting a net income of $247,768, up $82,173 from Q1 2020, attributed to a sales mix favoring more profitable Cryometrix products. However, overall revenue decreased to $562,362 from $983,808, reflecting the impact of site preparation delays for ULT freezer installations. Despite this, improved margins were reported due to the shift in product sales. The company remains focused on its technology in cryogenic cooling for various industries.

Reflect Scientific, Inc. (RSCF) shares insights from CEO Kim Boyce, detailing developments in cryogenic temperature control systems. Over ten years, the company has improved its non-mechanical systems, enhancing reliability and cost-effectiveness. Key products include the Cryometrix S-90 shipper, and interest is growing in applications for vaccine management and air freight. Reflect Scientific remains debt-free and filed a Form 10 Registration Statement with the SEC to become a fully-reporting issuer. The outlook is bullish as the company continues to receive inquiries from government and major corporations like Boeing and NASA.

Reflect Scientific, Inc. (RSCF) reported impressive financial results for the year ended December 31, 2020, posting total revenues of $2.79 million, a 74% increase from $1.61 million in 2019. The ultra-low temperature (ULT) freezers and solvent chillers generated $1.95 million in revenue, marking a 166% growth. Despite a slight 3.9% decline in chromatography supply revenue due to pandemic-related disruptions, net income improved to $660,000 compared to a loss of $196,000 in 2019. The company filed a Form 10 with the SEC to regain “fully reporting” status.

Reflect Scientific, Inc. (RSCF) is poised for growth as the ultra-low temperature freezer market expands, driven by increasing demand in vaccine development, organ preservation, and gene therapies. A recent Global Market Insights study highlights key growth trends, including advanced freezer technologies and rising demand in the Asia Pacific region. CEO Kim Boyce expressed optimism about the company’s alignment with these market needs, particularly with their liquid nitrogen cooled freezers. The firm aims to capitalize on the robust market potential backed by innovative technologies in cryogenic cooling.

Reflect Scientific Inc. (RSCF) reported a 23.7% increase in sales for the fourth quarter of 2020, totaling $695,823, compared to $562,314 in the same quarter of 2019. This growth was primarily driven by the Cryometrix ULT freezer product line. CEO Kim Boyce expressed satisfaction with the annual sales performance, stating the year ended on a positive note.

Reflect Scientific specializes in innovative cryogenic cooling technologies for the biotechnology, pharmaceutical, and transportation sectors.

Reflect Scientific, Inc. (RSCF) announced strong orders of $231K for its Cryometrix ultra-low temperature freezers, indicating robust demand in January 2021. CEO Kim Boyce noted that these freezers are becoming vital for the cold chain management in pharmaceuticals. The Cryometrix series employs patented liquid nitrogen cooling technology, offering superior reliability and performance compared to traditional freezers, with capacities ranging from 120 to 950 liters.

Reflect Scientific, Inc. (Symbol: RSCF) has launched a new ultra-low temperature freezer, the Cryometrix RDC-120, designed for efficient storage of vaccines and high-value biologicals. This freezer features patented liquid nitrogen cooling technology and can operate in a transportable, self-powered configuration. With a capacity of approximately 120 liters and a temperature range of 0C to -160C, it cools from room temperature to -80C in just 5 minutes. CEO Kim Boyce emphasized the freezer's versatility, making it suitable for various deployment scenarios. Orders for the RDC-120 are now being accepted.

Reflect Scientific has been awarded a patent for its Cryometrix S-90, a cryogenic shipping unit capable of maintaining temperatures as low as -90 degrees Celsius. This system enhances cold chain management for biologics, including COVID-19 vaccines, by eliminating the need for dry ice and ensuring temperature uniformity during transport.

The S-90 can ship up to 33.5 cubic feet (70,000 vials) of product, featuring advanced temperature logging and customizable settings. Reflect Scientific specializes in cryogenic cooling technologies for the biotechnology and pharmaceutical industries.